Formation of a catalytically active dimer by tRNAVal -driven short ribozymes
暂无分享,去创建一个
Masaya Orita | Kazunari Taira | Tomoko Kuwabara | Masaki Warashina | K. Taira | M. Orita | M. Warashina | T. Kuwabara | Jun Ohkawa | J. Ohkawa | Shiori Koseki | S. Koseki
[1] M. Caruthers,et al. Metal ion catalysis in the Tetrahymena ribozyme reaction , 1993, Nature.
[2] A. Ho,et al. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Steitz,et al. A general two-metal-ion mechanism for catalytic RNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. McLaughlin,et al. Hammerhead Ribozymes Containing Non-Nucleoside Linkers Are Active RNA Catalysts , 1994 .
[5] J L Sussman,et al. Crystal structure of yeast phenylalanine transfer RNA. I. Crystallographic refinement. , 1978, Journal of molecular biology.
[6] K. Taira,et al. Explanation by the double-metal-ion mechanism of catalysis for the differential metal ion effects on the cleavage rates of 5'-oxy and 5'-thio substrates by a hammerhead ribozyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Taira,et al. HAMMERHEAD MINIZYMES WITH HIGH CLEAVAGE ACTIVITY : A DIMERIC STRUCTURE AS THE ACTIVE CONFORMATION OF MINIZYMES , 1996 .
[8] P. Hendry,et al. In vitro activity of minimised hammerhead ribozymes. , 1995, Nucleic acids research.
[9] T. Cech,et al. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing , 1994, Nature.
[10] P. Hendry,et al. Minimal sequence requirements for ribozyme activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Taira,et al. Selection of the best target site for ribozyme-mediated cleavage within a fusion gene for adenovirus E1A-associated 300 kDa protein (p300) and luciferase. , 1996, Nucleic acids research.
[12] B. Stoddard,et al. Capturing the Structure of a Catalytic RNA Intermediate: The Hammerhead Ribozyme , 1996, Science.
[13] J. Yee,et al. Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. , 1994, Gene therapy.
[14] T. Tuschl,et al. Hammerhead ribozymes: importance of stem-loop II for activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Klug,et al. The crystal structure of an AII-RNAhammerhead ribozyme: A proposed mechanism for RNA catalytic cleavage , 1995, Cell.
[16] M. T. Hills,et al. [8] Structural studies of DNA three-way junctions , 1995 .
[17] W. Gerlach,et al. The Use of Ribozymes to Inhibit HIV Replication , 1996 .
[18] Y. Takebe,et al. Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] K. Taira,et al. Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes. , 1996, Nucleic acids research.
[20] K. Taira,et al. Magnesium-mediated Conversion of an Inactive Form of a Hammerhead Ribozyme to an Active Complex with Its Substrate , 1996, The Journal of Biological Chemistry.
[21] S. Altman,et al. A trinucleotide can promote metal ion-dependent specific cleavage of RNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] K. Taira,et al. The Hydrolysis of RNA: From Theoretical Calculations to the Hammerhead Ribozyme-Mediated Cleavage of RNA. , 1998, Chemical reviews.
[23] O. Uhlenbeck,et al. Role of divalent metal ions in the hammerhead RNA cleavage reaction. , 1991, Biochemistry.
[24] K. Flaherty,et al. Three-dimensional structure of a hammerhead ribozyme , 1994, Nature.
[25] O. Uhlenbeck,et al. Kinetic characterization of intramolecular and intermolecular hammerhead RNAs with stem II deletions. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] L. B. Weinstein,et al. A second catalytic metal ion in a group I ribozyme , 1997, Nature.
[27] D. Livingston,et al. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation , 1998, Nature.
[28] D. Engelke,et al. Expression of small, therapeutic RNAs in human cell nuclei , 1997, Gene Therapy.
[29] S. Altman,et al. RNA enzyme-directed gene therapy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] O. Heidenreich,et al. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. , 1992, The Journal of biological chemistry.
[31] M. Komiyama,et al. KINETIC EVIDENCE BASED ON SOLVENT ISOTOPE EFFECTS FOR THE NONEXISTENCE OF A PROTON-TRANSFER PROCESS IN REACTIONS CATALYZED BY A HAMMERHEAD RIBOZYME : IMPLICATION TO THE DOUBLE-METAL-ION MECHANISM OF CATALYSIS , 1995 .
[32] P. V. von Hippel,et al. A two-metal ion mechanism operates in the hammerhead ribozyme-mediated cleavage of an RNA substrate. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Rossi,et al. Ribozymes as potential anti-HIV-1 therapeutic agents. , 1990, Science.
[34] Transcription by RNA Polymerase III , 1988 .
[35] F. Wong-Staal,et al. Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial. , 1996, Gene Therapy.
[36] R. Pictet,et al. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. , 1997, RNA.
[37] R. Symons,et al. Self-cleavage of RNA in the replication of small pathogens of plants and animals. , 1989, Trends in biochemical sciences.
[38] Fritz Eckstein,et al. Nucleic acids and molecular biology , 1987 .
[39] A. Altman,et al. Construction and characterization of lck- and fyn-specific tRNA: ribozyme chimeras. , 1994, Molecular immunology.